07 Jan 2001

Cholipin 50 - España

Updated: 07 Jan 2001

Cholipin 50 grageas

Disquinesias biliares, espasmos biliares. Síndrome post-colecistectomía. Dispepsias por alteración de la secreción biliar. Litiasis biliar no obstructiva.

Cholipin 50 Description, Presentation and Dosage

Cholipin 50 Description

Cholipin 50 Drug Class Description

Colagogos y colereticos en asociacion salvo a05c

Cholipin 50 Drug Description

GRAGEAS

Cholipin 50 Presentation

Cholipin 50 Presentation

1-2 grageas 3 veces al día, preferentemente antes de las comidas.

Cholipin 50 Manufacturer

BOEHRINGER INGELHEIM

Related Learning Zones

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

Cystic fibrosis (CF) is a genetic condition caused by a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The Cystic Fibrosis Knowledge Centre provides healthcare professionals with access to disease awareness information, emerging and established treatment options and current best practice based on recently updated guidelines by the European Cystic Fibrosis Society (ECFS). A resources section contains external links to upcoming medical conferences and patient support groups.

This resource is developed by EPG Health Media for epgonline.org, supported by an independent educational grant from Vertex.

Type 1 Childhood Diabetes CME

Type 1 Childhood Diabetes CME

In this EACCME-accredited online CME activity Individual Patient Management in Type 1 Childhood Diabetes, healthcare professionals will learn how to assess the psychosocial wellbeing of young patients with type 1 diabetes. 

Upon successful completion of this activity, healthcare professionals (such as endocrinologists, paediatricians, paediatric endocrinologists, diabetes specialists, specialist nurses, primary care physicians) will be awarded 1 European CME credit (ECMEC).

Cholipin 50 Dosage

Cholipin 50 Precautions, Reactions and Contraindications

Cholipin 50 Special Precautions

Related Drugs - Gastroenterologia

Back to top